Home › Funds › DIADEMA PARTNERS LP › PTHS
DIADEMA PARTNERS LP position in PTHS
PELTHOS THERAPEUTICS INC · Health Care
DIADEMA PARTNERS LP reported holding 80,760 shares of PTHS (PELTHOS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.7M, representing 0.46% of its reported portfolio and ranking #45 among its reported holdings. DIADEMA PARTNERS LP has disclosed PTHS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How DIADEMA PARTNERS LP's PTHS position evolved
DIADEMA PARTNERS LP first disclosed a stake in PTHS in Q3 2025 at 10,498 shares (US$294K). The position peaked in Q3 2026 at 80,760 shares, worth US$1.7M. Across 5 filings, DIADEMA PARTNERS LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 80,760 shares valued at US$1.7M — an increase of 55,987 shares quarter over quarter.. Notable position changes include a 138% increase in Q4 2025 (shares fell 32% over the following quarter), a 226% increase in Q3 2026 (shares fell 65% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 10.50K | $293.94K | New |
| Q4 2025 | 25.00K | $775.00K | Add |
| Q1 2026 | 24.77K | $520.48K | Reduce |
| Q2 2026 | 24.77K | $700.09K | Hold |
| Q3 2026 | 80.76K | $1.70M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PTHS and 13F data
PTHS (PELTHOS THERAPEUTICS INC) is a Health Care company. 29 other funds we track also report a position in PTHS — the largest reported positions include Ikarian Capital, LLC (US$7.3M), Murchinson Ltd. (US$6.5M), AIGH Capital Management LLC (US$5.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PTHS
- Ikarian Capital, LLC 256.60K sh · $7.25M · Q2 2026
- Murchinson Ltd. 311.02K sh · $6.53M · Q3 2026
- AIGH Capital Management LLC 256.01K sh · $5.38M · Q3 2026
- WEXFORD CAPITAL LP 84.62K sh · $1.78M · Q3 2026
- Knott David M Jr 17.64K sh · $370.70K · Q3 2026
- Pale Fire Capital SE 12.92K sh · $271.43K · Q3 2026
More on DIADEMA PARTNERS LP
FAQ
How long has DIADEMA PARTNERS LP held PTHS?
DIADEMA PARTNERS LP has disclosed PTHS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is DIADEMA PARTNERS LP's current position in PTHS?
As of Q3 2026, DIADEMA PARTNERS LP holds 80.76K shares of PTHS (PELTHOS THERAPEUTICS INC), valued at $1.70M, representing 0.46% of its reported portfolio and ranking #45.
Has DIADEMA PARTNERS LP been buying or selling PTHS?
In the latest 13F filing (Q3 2026), DIADEMA PARTNERS LP increased its position in PTHS. The position peaked in Q3 2026 at 80.76K shares.
Which other funds hold PTHS?
Other major institutional holders of PTHS include Ikarian Capital, LLC, Murchinson Ltd., AIGH Capital Management LLC, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.